Botox Approved for Platysma Bands

The US Food and Drug Administration (FDA) has approved BOTOX® Cosmetic for temporary improvement in the appearance of moderate-to-severe vertical bands connecting the jaw and neck (platysma bands) in adults, Allergan Aesthetics, an AbbVie company, announced.

According to a press release, BOTOX®Cosmetic became the first product of its kind to go beyond the face and the first with four aesthetic indication areas: forehead lines, frown lines, crow's feet lines, and now platysma bands.

"Research shows millions of consumers in the US are extremely or very bothered by their platysma bands. Until now, treatment options have been limited and with this approval, there is a nonsurgical, injectable option to temporarily improve the look of vertical bands connecting the jaw and neck," Darin J. Messina, Ph.D., Senior Vice President, Aesthetics R&D at Allergan Aesthetics, said in the press release. "This fourth indication for BOTOX®Cosmetic represents true innovation. We're excited to open new doors for patients and providers, helping them to achieve their aesthetic goals."

By injecting along the jawline and the vertical bands connecting the jaw and neck with one of the FDA-approved doses of BOTOX® Cosmetic based on severity—26, 31, or 36 units—BOTOX® Cosmetic temporarily reduces underlying muscle activity.

"In my practice, the neck and lower face are always a standard part of my comprehensive aesthetic consultation. Many of my patients are often surprised by the significant impact that changes in these areas can have," Dr. Terrence Keaney, board-certified dermatologist and pivotal clinical trial investigator, said in a press release. "With the approval of BOTOX® Cosmetic for the treatment of platysma bands, including precise injection patterns and dosing, I can now confidently offer my patients a treatment option that can help deliver the results they are looking to achieve."